Clinimix 384 mg (Histidine SOLUTION) 384 MG

Clinimix 384 mg is an intravenous solution containing histidine, designed to support nutritional needs. It's commonly used in clinical settings for patients requiring parenteral nutrition.

Strength

384 MG

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Clinimix 384 mg is primarily used to provide essential amino acids, including histidine, to patients who cannot absorb nutrients through the digestive system. This intravenous solution supports overall health and helps maintain proper metabolic function. It is often administered in hospitals or clinical settings under medical supervision.

Side Effects

When administered as directed, Clinimix 384 mg provides the body with necessary amino acids to support various biological processes. Patients may experience improved nutritional status and better overall health outcomes. However, individual responses can vary.

Precautions & Warnings

Clinimix 384 mg should be handled with care and administered by healthcare professionals. It is important to follow proper hygiene and safety protocols when using this intravenous solution. Patients with known allergies to any of the components should avoid using this product.

Avoid Interactions

Clinimix 384 mg may interact with other medications or supplements. It is important to inform healthcare providers about all current medications before starting this treatment. Alcohol and certain foods may also affect the efficacy of this solution.

Frequently Asked Questions

Clinimix 384 mg is used to provide essential amino acids, including histidine, to patients who cannot absorb nutrients through the digestive system.

Clinimix 384 mg is administered intravenously, typically in a clinical setting under medical supervision.

Clinimix 384 mg provides the body with necessary amino acids to support various biological processes, potentially improving nutritional status and overall health.

Yes, Clinimix 384 mg should be handled with care and administered by healthcare professionals. Patients with known allergies to any of the components should avoid using this product.

Yes, Clinimix 384 mg may interact with other medications or supplements. It is important to inform healthcare providers about all current medications before starting this treatment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.